-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-519116-14-00
4
2025-05-27
Asthma
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-513959-33-00
4
2025-05-13
Asthma
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-511435-10-00
1
2025-04-30
Hepatocellular Carcinoma
-
2023-504086-23-00
5
2025-03-27
Subjects with PBC with a non-optimal response to UDCA.
-
2023-507937-14-00
7
2025-03-25
Metastatic Solid Tumor
-
2024-514281-39-00
5
2025-02-14
Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD
-
2024-515008-38-00
5
2025-02-14
Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Expres
-
2023-506706-40-00
10
2025-02-11
Mantle-Cell Lymphoma
-
2023-508798-94-00
5
2025-02-11
Heart failure
-
2024-516372-14-00
11
2025-01-13
Asymptomatic Patients with frequent PVCs and normal LVEF
-
2023-509883-89-00
5
2025-01-09
Epidermal growth factor receptor (EGFR) mutation-positive, locally adv
-
2023-507544-37-00
5
2025-01-08
patients with end-stage renal disease on chronic peritoneal dialysis a
-
2023-510507-21-00
10
2025-01-08
Intersitial lung disease related to systemic sclerosis
-
2023-510109-16-00
4
2025-01-06
Acute Respiratory Distress Syndrome (ARDS) Due to Pneumonia or other I
-
2023-505048-20-00
4
2024-12-20
Arrhythmogenic right ventricular dysplasia
-
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
-
2023-503602-37-00
5
2024-12-16
Cardiogenic Shock
-
2023-510150-17-00
4
2024-12-11
Active, refractory systemic lupus erythematosus (SLE), and active, re
-
2023-510380-34-00
4
2024-12-10
Diffuse cutaneous systemic sclerosis (dcSSc)
-
2024-512895-36-00
5
2024-11-25
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
2024-512113-41-00
5
2024-11-20
Severe Asthma